Applications and progress of methods for estimating opioids requirements

doi:10.19803/j.1672-8629.20230607

Abstract

Abstract: Objective To sort out the current status and existing problems in the application of estimation methods for opioid requirements, and to make suggestions for promoting the rational use of medication and improving estimation methods. Methods The related literature and documents from CNKI, Wanfang Data, PubMed, International Narcotics Control Boardwere were searched and analysed. Results There are three main methods for estimating opioid demand in the international arena, which have different data requirements and their own advantages and disadvantages. Conclusion In the context of existing problems, it is recommended that the regulator invest more resources to continuously improve the development of rules for estimation methods and the quality of drug data records and improve the drug estimation system in order to promote the rational use of opioids.

Key words: opioids, requirements, system of estimates, estimation of requirements, rational drug use, supervision

CLC Number:

R971
R954

LI Wenpeng, ZHOU Huziwei, ZHU Lan, WANG Shengfeng. Applications and progress of methods for estimating opioids requirements[J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 519-523.

Add to citation manager EndNote|Ris|BibTeX

URL: https://www.zgywjj.com/EN/10.19803/j.1672-8629.20230607

https://www.zgywjj.com/EN/Y2024/V21/I5/519

References

[1] YOO M, PERRET D, DUSTO N, et al.Pain and addiction: the distribution of supply and demand during the opioid epidemic[J]. Am J Phys Med Rehabil, 2022, 101(7): 702-707.
[2] ZHANG L, HUANG XX, LIU KK, et al.Research progress of opioid management in China[J]. Oncology Pharmacy(肿瘤药学), 2023, 13(1): 17-22.
[3] TIAN Y, XU ZY, GUAN XD, et al.Analysis of opioid use in China from 2014 to 2016[J]. Chinese Pharmacy(中国药房), 2019, 30(9): 1153-1157.
[4] International Narcotics Control Board. Guidelines for Estimating International Controlled Drugs(国际管制药物估算指南)[M]. New York: English, Publications and Books Section, United Nations Office at Vienna, 2012.
[5] International Narcotics Control Board. Report of the International Narcotics Control Board 2022(国际麻醉品管制局2022年报告)[R]. New York: English, Publications and Books, United Nations Office at Vienna, 2023.
[6] CLARK J, CROWTHER L, JOHNSON MJ, et al.Calculating worldwide needs for morphine for pain in advanced cancer and proportions feasibly met by country estimates of requirements and consumption. retrospective, time-series analysis (1997-2017)[J]. PLOS Glob Public Health, 2022, 2(7): 533.
[7] GOODMAN-MEZA D, FRIEDMAN J, KALMIN MM, et al.Geographical and socioeconomic disparities in opioid access in Mexico, 2015-19: a retrospective analysis of surveillance data[J]. Lancet Public Health, 2021, 6(2): e88-e96.
[8] HUANG Z, SU X, DIAO Y, et al.Clinical consumption of opioid analgesics in China: a retrospective analysis of the national and regional data 2006-2016[J]. J Pain Symptom Manage, 2020, 59(4): 829-835.
[9] CONNOR S, SISIMAYI C, DOWNING J, et al.Assessment of the need for palliative care for children in South Africa[J]. Int J Palliat Nurs, 2014, 20(3): 130-134.
[10] AZUMA K, ABE H, HOZUMI J, et al.Prefectural adequacy of opioid availability for cancer pain and its determinants in Japan: a preliminary study[J]. JMA J, 2020, 3(4): 340-346.
[11] YANG SL, WOON YL, TEOH CCO, et al.Adult palliative care 2004-2030 population study: estimates and projections in Malaysia[J]. BMJ Support Palliat Care, 2022, 12(e1): e129-e136.
[12] ETKIND SN, BONE AE, GOMES B, et al.How many people will need palliative care in 2040? past trends, future projections and implications for services[J]. BMC Med, 2017, 15(1): 102.
[13] REJAS-GUTIERREZ J, SICRAS-MAINAR A, DARBÀ J.Future projections of opioid use and cost in patients with chronic osteoarthritis pain in Spain[J]. Ther Adv Musculoskelet Dis, 2021, 13: 1-19.
[14] DZOTSENIDZE P, MAURER MA, KORDZAIA D, et al.The contribution of the international pain policy fellowship in improving opioid availability in Georgia[J]. J Pain Symptom Manage, 2017, 54(5): 749-757.
[15] FORTUNA D, CASELLI L, BANCHELLI F, et al.How many cancer patients need palliative care? a population-based study[J]. J Pain Symptom Manage, 2022, 63(4): 468-475.
[16] TREISH IM, HAMMOUDEH SS, SALMANY SS, et al.Should INCB consumption data be utilized to guide opioids policy?[J]. J Pain Symptom Manage, 2022, 63(5): e481-e487.
[17] BÄCKRYD E, HEILIG M, HOFFMANN M. Opioid availability statistics from the International Narcotics Control Board do not reflect the medical use of opioids: comparison with sales data from Scandinavia[J]. Scand J Pain, 2021, 21(4): 696-706.
[18] NESOFF ED, MARTINS SS, PALAMAR JJ.Caution is necessary when estimating treatment need for opioid use disorder using national surveys[J]. Am J Public Health, 2022, 112(2): 199-201.
[19] CLARK J, GNANAPRAGASAM S, GREENLEY S, et al.Perceptions and experiences of laws and regulations governing access to opioids in South, Southeast, East and Central Asia: a systematic review, critical interpretative synthesis and development of a conceptual framework[J]. Palliat Med, 2021, 35(1): 59-75.
[20] SEYA MJ, GELDERS SF, ACHARA OU, et al.A first comparison between the consumption of and the need for opioid analgesics at country, regional, and global levels[J]. J Pain Palliat Care Pharmacother, 2011, 25(1): 6-18.
[21] ZHI NJ, WEI XM, GAO X, et al.Analysis of clinical use of opioid analgesics in China[J]. Journal of Pharmacoepidemiology(药物流行病学杂志), 2018, 27(6): 400-405.
[22] RICE J, KANNAN AM, CASTRIGNANÒ E, et al.Wastewater-based epidemiology combined with local prescription analysis as a tool for temporalmonitoring of drugs trends - a UK perspective[J]. Sci Total Environ, 2020, 735: 1-13.
[23] International Narcotics Control Board. Report of the International Narcotics Control Board 2014(国际麻醉品管制局2014年报告)[R]. New York: English, Publications and Books, United Nations Office at Vienna, 2015.
[24] International Narcotics Control Board. Progress in Ensuring Adequate Supplies of Internationally Controlled Drugs for Medical and Scientific Purposes[R]. New York: English, Publications and Books, United Nations Office at Vienna, 2019.
[25] LIU Y, WU XM, GU JQ.The development of narcotic drug supervision in China and its external enlightenment[J]. Chinese Journal of New Drugs(中国新药杂志), 2015, 24(22): 2540-2543, 2554.
[26] NMPA.The Annual Report on National Drug Abuse Monitoring (2016)[EB/OL]. (2017-08-11)[2024-02-23]. https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20170811104001233.html.
[27] XIE LX, DENG YP, SHI LW.Opioid abuse crisis in the United Stataes and analgesic use and regulation in China[J]. Chinese Journal of Drug Abuse Control(中国药物滥用防治杂志), 2020, 26(4): 192-197.